EKF Diagnostics Holdings plc (LON:EKF – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 29.20 ($0.37) and traded as low as GBX 27.18 ($0.34). EKF Diagnostics shares last traded at GBX 28.05 ($0.35), with a volume of 116,932 shares trading hands.
EKF Diagnostics Price Performance
The company has a debt-to-equity ratio of 6.01, a quick ratio of 1.77 and a current ratio of 2.69. The company’s fifty day simple moving average is GBX 29.97 and its two-hundred day simple moving average is GBX 29.20. The stock has a market capitalization of £127.27 million, a PE ratio of 2,805.00 and a beta of 0.56.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
See Also
- Five stocks we like better than EKF Diagnostics
- Manufacturing Stocks Investing
- RXO Shares Surge Following New Acquisition Deal
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- What Are Dividend Champions? How to Invest in the Champions
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
